139 related articles for article (PubMed ID: 31189610)
1. The enemy of my enemy: PTEN and PLCXD collude to fight endosomal PtdIns(4,5)P
Del Signore SJ; Rodal AA
J Cell Biol; 2019 Jul; 218(7):2082-2083. PubMed ID: 31189610
[TBL] [Abstract][Full Text] [Related]
2. PTEN reduces endosomal PtdIns(4,5)P
Mondin VE; Ben El Kadhi K; Cauvin C; Jackson-Crawford A; Bélanger E; Decelle B; Salomon R; Lowe M; Echard A; Carréno S
J Cell Biol; 2019 Jul; 218(7):2198-2214. PubMed ID: 31118240
[TBL] [Abstract][Full Text] [Related]
3. Rab35 GTPase Triggers Switch-like Recruitment of the Lowe Syndrome Lipid Phosphatase OCRL on Newborn Endosomes.
Cauvin C; Rosendale M; Gupta-Rossi N; Rocancourt M; Larraufie P; Salomon R; Perrais D; Echard A
Curr Biol; 2016 Jan; 26(1):120-8. PubMed ID: 26725203
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol signalling reactions.
Zhang X; Majerus PW
Semin Cell Dev Biol; 1998 Apr; 9(2):153-60. PubMed ID: 9599410
[TBL] [Abstract][Full Text] [Related]
5. Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL.
De Leo MG; Staiano L; Vicinanza M; Luciani A; Carissimo A; Mutarelli M; Di Campli A; Polishchuk E; Di Tullio G; Morra V; Levtchenko E; Oltrabella F; Starborg T; Santoro M; Di Bernardo D; Devuyst O; Lowe M; Medina DL; Ballabio A; De Matteis MA
Nat Cell Biol; 2016 Aug; 18(8):839-850. PubMed ID: 27398910
[TBL] [Abstract][Full Text] [Related]
6. Loss of OCRL increases ciliary PI(4,5)P
Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y
J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046
[TBL] [Abstract][Full Text] [Related]
7. Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P
Chen H; Lu C; Tan Y; Weber-Boyvat M; Zheng J; Xu M; Xiao J; Liu S; Tang Z; Lai C; Li M; Olkkonen VM; Yan D; Zhong W
J Biol Chem; 2023 Jun; 299(6):104812. PubMed ID: 37172724
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide phosphatases: just as important as the kinases.
Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
[TBL] [Abstract][Full Text] [Related]
9. Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus.
Suchy SF; Olivos-Glander IM; Nussabaum RL
Hum Mol Genet; 1995 Dec; 4(12):2245-50. PubMed ID: 8634694
[TBL] [Abstract][Full Text] [Related]
10. IPIP27 Coordinates PtdIns(4,5)P
Carim SC; Ben El Kadhi K; Yan G; Sweeney ST; Hickson GR; Carréno S; Lowe M
Curr Biol; 2019 Mar; 29(5):775-789.e7. PubMed ID: 30799246
[TBL] [Abstract][Full Text] [Related]
11. Regulation of phosphoinositide signaling by the inositol polyphosphate 5-phosphatases.
Astle MV; Seaton G; Davies EM; Fedele CG; Rahman P; Arsala L; Mitchell CA
IUBMB Life; 2006 Aug; 58(8):451-6. PubMed ID: 16916781
[TBL] [Abstract][Full Text] [Related]
12. OCRL controls trafficking through early endosomes via PtdIns4,5P₂-dependent regulation of endosomal actin.
Vicinanza M; Di Campli A; Polishchuk E; Santoro M; Di Tullio G; Godi A; Levtchenko E; De Leo MG; Polishchuk R; Sandoval L; Marzolo MP; De Matteis MA
EMBO J; 2011 Oct; 30(24):4970-85. PubMed ID: 21971085
[TBL] [Abstract][Full Text] [Related]
13. The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane.
Ivetac I; Munday AD; Kisseleva MV; Zhang XM; Luff S; Tiganis T; Whisstock JC; Rowe T; Majerus PW; Mitchell CA
Mol Biol Cell; 2005 May; 16(5):2218-33. PubMed ID: 15716355
[TBL] [Abstract][Full Text] [Related]
14. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate.
Zhang X; Hartz PA; Philip E; Racusen LC; Majerus PW
J Biol Chem; 1998 Jan; 273(3):1574-82. PubMed ID: 9430698
[TBL] [Abstract][Full Text] [Related]
15. Rab35 GTPase and OCRL phosphatase remodel lipids and F-actin for successful cytokinesis.
Dambournet D; Machicoane M; Chesneau L; Sachse M; Rocancourt M; El Marjou A; Formstecher E; Salomon R; Goud B; Echard A
Nat Cell Biol; 2011 Jun; 13(8):981-8. PubMed ID: 21706022
[TBL] [Abstract][Full Text] [Related]
16. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
[TBL] [Abstract][Full Text] [Related]
17. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.
Ooms LM; Horan KA; Rahman P; Seaton G; Gurung R; Kethesparan DS; Mitchell CA
Biochem J; 2009 Apr; 419(1):29-49. PubMed ID: 19272022
[TBL] [Abstract][Full Text] [Related]
18. The phosphoinositide 3-kinase inhibitor alpelisib restores actin organization and improves proximal tubule dysfunction in vitro and in a mouse model of Lowe syndrome and Dent disease.
Berquez M; Gadsby JR; Festa BP; Butler R; Jackson SP; Berno V; Luciani A; Devuyst O; Gallop JL
Kidney Int; 2020 Oct; 98(4):883-896. PubMed ID: 32919786
[TBL] [Abstract][Full Text] [Related]
19. PtdIns(4,5)P2-mediated cell signaling: emerging principles and PTEN as a paradigm for regulatory mechanism.
Gericke A; Leslie NR; Lösche M; Ross AH
Adv Exp Med Biol; 2013; 991():85-104. PubMed ID: 23775692
[TBL] [Abstract][Full Text] [Related]
20. Control of the signaling role of PtdIns(4)P at the plasma membrane through H
Jo SI; Kim S; Lim JM; Rhee SG; Jeong BG; Cha SS; Chang JB; Kang D
Redox Biol; 2024 May; 71():103097. PubMed ID: 38442648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
